Research
Hormonal
Current pharmacotherapy options for obesity include agents like liraglutide, semaglutide, and tirzepatide.
Practitioners should be aware of these specific pharmacotherapy options for treating obesity.
StrongSupportsmedium confidence
Agents like liraglutide, semaglutide, and tirzepatide supported by key clinical trials... have demonstrated remarkable efficacy in promoting weight loss and improving metabolic outcomes.
Why this rating
Supported by key clinical trials mentioned in the abstract.
Source
Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management
Ibrahim S. Alhomoud et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2024
reviewCited 19×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →